Skip to main content
editorial
. 2017 Aug 29;6(4):253–263. doi: 10.1159/000479573

Table 5.

Stratification factors in first-line phase III clinical trials in hepatocellular carcinoma

Study arm vs. placebo arm SUN1170 (sunitinib) BRISK-FL (brivanib) LiGHT (linifanib) SEARCH (+erlotinib) CheckMate-459 (nivolumab) REFLECT (lenivatinib)
Stratification factor Region
Vascular invasion and/or extrahepatic spread
Prior TACE
ECOG-PS score
Extrahepatic spread and/or vascular invasion
Study site
Region
ECOG-PS score
Vascular invasion and/or extrahepatic spread
Hepatitis B virus infection
Region
ECOG-PS score
Vascular invasion and/or extrahepatic spread
Smoking status
Etiology
Region
Vascular invasion and/or extrahepatic spread
Region
ECOG-PS score
Vascular invasion and/or extrahepatic spread
Body weight